Ocuphire Pharma Income After Taxes 2010-2024 | IRD
Ocuphire Pharma income after taxes from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
| Ocuphire Pharma Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2023 | $-10 |
| 2022 | $18 |
| 2021 | $-57 |
| 2020 | $-25 |
| 2019 | $-6 |
| 2018 | $-14 |
| 2017 | $-25 |
| 2016 | $-9 |
| 2015 | $-14 |
| 2014 | $-19 |
| 2013 | $-9 |
| 2012 | $-6 |
| 2011 | $-11 |
| 2010 | $-14 |
| 2009 | $-3 |
| Ocuphire Pharma Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-8 |
| 2024-03-31 | $-7 |
| 2023-12-31 | $-5 |
| 2023-09-30 | $6 |
| 2023-06-30 | $-5 |
| 2023-03-31 | $-6 |
| 2022-12-31 | $34 |
| 2022-09-30 | $-5 |
| 2022-06-30 | $-5 |
| 2022-03-31 | $-7 |
| 2021-12-31 | $-6 |
| 2021-09-30 | $-4 |
| 2021-06-30 | $-7 |
| 2021-03-31 | $-39 |
| 2020-12-31 | $-19 |
| 2020-09-30 | $-1 |
| 2020-06-30 | $-2 |
| 2020-03-31 | $-3 |
| 2019-12-31 | $1 |
| 2019-09-30 | $-2 |
| 2019-06-30 | $-2 |
| 2019-03-31 | $-2 |
| 2018-12-31 | $-3 |
| 2018-09-30 | $-5 |
| 2018-06-30 | $-4 |
| 2018-03-31 | $-2 |
| 2017-12-31 | $-4 |
| 2017-09-30 | $-1 |
| 2017-06-30 | $1 |
| 2017-03-31 | $-22 |
| 2016-12-31 | $-1 |
| 2016-09-30 | $-3 |
| 2016-06-30 | $-2 |
| 2016-03-31 | $-4 |
| 2015-12-31 | $-3 |
| 2015-09-30 | $-4 |
| 2015-06-30 | $-3 |
| 2015-03-31 | $-4 |
| 2014-12-31 | $-2 |
| 2014-09-30 | $-2 |
| 2014-06-30 | $0 |
| 2014-03-31 | $-15 |
| 2013-12-31 | $-3 |
| 2013-09-30 | $-2 |
| 2013-06-30 | $-3 |
| 2013-03-31 | $-2 |
| 2012-12-31 | $-0 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-1 |
| 2012-03-31 | $-2 |
| 2011-12-31 | $0 |
| 2011-09-30 | $-1 |
| 2011-06-30 | $-6 |
| 2011-03-31 | $-4 |
| 2010-12-31 | $-3 |
| 2010-09-30 | $0 |
| 2010-06-30 | $-4 |
| 2010-03-31 | $-8 |
| 2009-12-31 | $2 |
| 2009-09-30 | $-1 |
| 2009-06-30 | $-2 |
| 2009-03-31 | $-1 |
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fanhua (AIFU) | China | $0.086B | 2.07 |
| Top KingWin (WAI) | China | $0.008B | 0.00 |
| S&W Seed (SANW) | United States | $0.006B | 0.00 |
| Invo BioScience (NAYA) | United States | $0.004B | 0.00 |